EVOLET’s integrated R&D capabilities support the development of safe, effective, scalable, and commercially viable pharmaceutical products for domestic and international markets.
Our structured, science & risk-based approach combines formulation and analytical development, technology transfer, regulatory support, intellectual property management, and lifecycle management, with a strong focus on Quality by Design (QbD), Design of Experiments (DoE), data integrity, regulatory compliance, and continuous improvement.
Our R&D capabilities include:
Our development approach supports a broad range of pharmaceutical dosage forms, depending upon organizational manufacturing capabilities and market requirements, including:
Tablets, film-coated tablets, modified-release formulations, capsules, powders, granules, sachets and other oral solid delivery systems.
Oral liquids, suspensions, topical preparations, creams, ointments, gels and related dosage forms.
Injectable products, lyophilized formulations, ophthalmic preparations and other specialized drug-delivery systems, subject to facility capabilities and regulatory requirements.
Our multidisciplinary teams work collaboratively across R&D, Quality, Regulatory Affairs, Manufacturing, Engineering, Supply Chain and Commercial functions to ensure efficient development and successful commercialization.
